Publication Name	World Journal of Virology
Manuscript ID	14880
Country	Taiwan

Received	2014-10-29 08:51
Peer-Review Started	2014-10-29 16:21
To Make the First Decision	2014-12-12 17:27
Return for Revision	2014-12-16 12:27
Revised	2014-12-25 11:50
Second Decision	2015-01-08 17:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-01-19 13:43
Articles in Press	2015-01-19 13:43
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-01-24 15:32
Typeset the Manuscript	2015-04-17 17:27
Publish the Manuscript Online	2015-04-30 17:58

ISSN	2220-3249 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Minireviews
Article Title	Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples
Manuscript Source	Invited Manuscript
All Author List	Ming-Yih Wu and Hong-Nerng Ho
Funding Agency and Grant Number
Corresponding Author	Hong-Nerng Ho, MD, Department of Obstetrics and Gynecology, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei 10002, Taiwan. hnho@ntu.edu.tw
Key Words	Highly active antiretroviral therapy; human immunodeficiency virus-1 discordant; Seroconversion; Intrauterine insemination; Intracytoplasmic sperm injection
Core Tip	For human immunodeficiency virus type-1 (HIV-1)-infected men and uninfected women, highly active antiretroviral therapy, sperm washing and HIV-1 viral load check by RT-polymerase chain reaction have become the standard procedure to enable conception. Although the risk of seroconversion of HIV infection is very low, it remains possible. Intrauterine insemination may introduce more risk of HIV-1 transmission and also possesses less chance of pregnancy compared to in vitro fertilization-intracytoplasmic sperm injection (ICSI). Therefore, ICSI may be the preferred choice.
Publish Date	2015-04-30 17:58
Citation	Wu MY, Ho HN. Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples. World J Virol 2015; 4(2): 142-146
URL	http://www.wjgnet.com/2220-3249/full/v4/i2/142.htm
DOI	http://dx.doi.org/10.5501/wjv.v4.i2.142

Full Article (PDF)	WJV-4-142.pdf
Full Article (Word)	WJV-4-142.doc
Manuscript File	14880-Review.docx
Answering Reviewers	14880-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14880-Conflict-of-interest statement.pdf
Copyright License Agreement	14880-Copyright assignment.pdf
Peer-review Report	14880-Peer review(s).pdf
Scientific Misconduct Check	14880-CrossCheck.jpg
Scientific Editor Work List	14880-Scientific editor work list.pdf